Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COMETRIQ for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 28 adverse event reports in the FDA FAERS database where COMETRIQ was used for Prostate cancer.

Most Reported Side Effects for COMETRIQ

Side Effect Reports % Deaths Hosp.
Off label use 75 49.7% 19 11
Fatigue 48 31.8% 8 9
Diarrhoea 39 25.8% 10 7
Stomatitis 29 19.2% 2 6
Nausea 23 15.2% 2 6
Death 20 13.3% 20 7
Decreased appetite 18 11.9% 6 4
Dry mouth 16 10.6% 0 1
Malignant neoplasm progression 16 10.6% 13 3
Pain in extremity 16 10.6% 1 1
Dysgeusia 15 9.9% 0 2
Dysphonia 15 9.9% 3 2
Asthenia 14 9.3% 3 7
Dyspnoea 13 8.6% 4 3
Hair colour changes 10 6.6% 0 1

Other Indications for COMETRIQ

Thyroid cancer (64) Renal cancer (18) Medullary thyroid cancer (10) Lung neoplasm malignant (7)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

COMETRIQ Full Profile All Prostate cancer Drugs COMETRIQ Demographics COMETRIQ Timeline